Psychiatry and Neurology, Neurology · Chandler, AZ
NPI
1386898419
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2201 W Fairview St Ste 1
Chandler, AZ, 85224
Phone (480) 800-4890
Groups this clinician bills Medicare through
Medicare paid, 2024
$125K
4,591 services
Medicare patients, 2024
445
Average age 75
Drug cost, 2024
$2.4M
2,170 prescriptions
Company payments, 2025
$2,802
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian L Rabin was code A9575 (injection, gadoterate meglumine, 0.1 ml), 3,100 times for 30 patients. In total Brian L Rabin billed 4,591 services in 41 codes, and Medicare paid $125K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| A9575 Injection, gadoterate meglumine, 0.1 ml | Office | 3,100 | 30 | $0.10 | $298 |
| 99213 Office E&M - Established | Office | 361 | 261 | $56.28 | $20K |
| 96133 Behavioral Health Services | Office | 295 | 42 | $66.14 | $20K |
| 99214 Office E&M - Established | Office | 228 | 172 | $86.13 | $20K |
| 99204 Office E&M - New | Office | 108 | 108 | $103.49 | $11K |
| 95886 Electrical Nerve Conductivity | Office | 92 | 40 | $63.53 | $5,845 |
| 99203 Office E&M - New | Office | 48 | 48 | $65.98 | $3,167 |
| 99215 Office E&M - Established | Office | 44 | 39 | $117.47 | $5,169 |
| 96132 Behavioral Health Services | Office | 43 | 42 | $88.03 | $3,785 |
| 76377 Standard X-ray | Office | 36 | 32 | $33.29 | $1,198 |
| 70551 MRI/MRA - Head and Neck | Office | 35 | 35 | $85.30 | $2,986 |
| 70553 MRI/MRA - Head and Neck | Office | 24 | 24 | $131.52 | $3,157 |
| 95816 Neurologic | Office | 18 | 18 | $269.36 | $4,848 |
| 95911 Electrical Nerve Conductivity | Office | 16 | 15 | $126.09 | $2,017 |
| 95910 Electrical Nerve Conductivity | Office | 15 | 15 | $116.73 | $1,751 |
By year: 2022 $110K for 6,271 services; 2023 $196K for 10,636 services; 2024 $125K for 4,591 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brian L Rabin prescribed most often to Medicare patients was Donepezil Hcl, with 271 prescriptions and refills. In total Brian L Rabin wrote 2,170 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 271 | 471 | 96 | $2,393 |
| Gabapentin Generic | 257 | 372 | 81 | $5,445 |
| Pregabalin Generic | 87 | 115 | 24 | $1,793 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 86 | 144 | 27 | $1,661 |
| Memantine Hcl Generic | 84 | 114 | 31 | $1,074 |
| Levetiracetam Generic | 61 | 101 | 20 | $1,233 |
| Emgality Pen Galcanezumab-Gnlm | 53 | 55 | Under 11 | $38K |
| Dalfampridine Er Dalfampridine | 53 | 71 | 12 | $11K |
| Amantadine Amantadine Hcl | 47 | 69 | Under 11 | $2,018 |
| Tizanidine Hcl Generic | 46 | 56 | 14 | $1,083 |
| Lorazepam Generic | 45 | 45 | 38 | $57.07 |
| Hydroxyzine Hcl Generic | 42 | 55 | 13 | $873 |
| Primidone Generic | 41 | 83 | 11 | $1,874 |
| Donepezil Hcl Odt Donepezil Hcl | 38 | 70 | Under 11 | $775 |
| Topiramate Generic | 38 | 76 | 14 | $430 |
Brand drugs: - claims; generic drugs: 1,816 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian L Rabin $2,802 ($2,802 in general payments such as food, travel and fees) from 23 companies. The largest payer was Abbvie Inc. with $476.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 24 | $476 |
| Argenx US, Inc. ARGX | 11 | $314 |
| Lundbeck LLC | 12 | $237 |
| Eisai Inc. 4523.T | 8 | $207 |
| Pfizer Inc. PFE | 11 | $198 |
| Teva Pharmaceuticals USA, Inc. TEVA | 8 | $196 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $165 |
| ACADIA Pharmaceuticals Inc ACAD | 7 | $162 |
| UCB, Inc. UCB.BR | 5 | $123 |
| Celgene Corporation BMY | 5 | $112 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.